Invention Grant
- Patent Title: Anti-CLauDiN 18 antibodies and methods of use thereof
-
Application No.: US17427909Application Date: 2020-02-03
-
Publication No.: US11407828B2Publication Date: 2022-08-09
- Inventor: Han Li , Ming Lei , Yi Pei , Haichun Huang
- Applicant: NovaRock Biotherapeutics, Ltd.
- Applicant Address: US NJ Ewing Township
- Assignee: NovaRock Biotherapeutics, Ltd.
- Current Assignee: NovaRock Biotherapeutics, Ltd.
- Current Assignee Address: US NJ Ewing Township
- Agency: Morse, Barnes-Brown & Pendleton, P.C.
- Agent Lisa M. Warren, Esq.; Erin E. Bryan, Esq.
- International Application: PCT/US2020/016459 WO 20200203
- International Announcement: WO2020/160560 WO 20200806
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
Antibodies that specifically bind to the human tight junction molecule CLDN18.2 and have functional properties that make them suitable for use in antibody-based immunotherapies of a disease associated with aberrant expression of CLDN18.2 are disclosed.
Information query
